Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Lung Neoplasms and CREBBP[original query] |
|---|
| Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer. Respiratory research 2019 Nov 20 (1): 248. Zhou Mengting, Fan Jun, Li Zhenyu, Li Pindong, Sun Yajie, Yang Yuhui, Zhou Xiaoshu, Wang Jing, Wang Ye, Qi Huiwei, Cai Weijing, Dai Xiaofang, Hirsch Fred |
| Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies. International journal of cancer 2019 Oct . Qian Jie, Nie Wei, Lu Jun, Zhang Lele, Zhang Yanwei, Zhang Bo, Wang Shuyuan, Hu Minjuan, Xu Jianlin, Lou Yuqing, Dong Yu, Niu Yanjie, Yan Bo, Zhong Runbo, Zhang Wei, Chu Tianqing, Zhong Hua, Han Baoh |
| [Analysis of the feasibility and prognostic value of circulating tumor DNA in detecting gene mutations in small cell lung cancer]. Zhonghua yi xue za zhi 2020 12 100 (45): 3614-3621. Jin Y, Chen Y M, Hu X, Tang H R, Yu X M, Fan Y, Xu Y J, Xu H M, Li P S, Li Q, Chang L P, Guan Y F, Chen |
| Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model. Cancer genetics 2020 1 241 51-56. Kunimasa Kei, Hirotsu Yosuke, Nakamura Harumi, Tamiya Motohiro, Iijima Yuki, Ishida Hiroto, Hamamoto Yuichiro, Maniwa Tomohiro, Kimura Toru, Nishino Kazumi, Goto Taichiro, Amemiya Kenji, Mochizuki Hitoshi, Oyama Toshio, Nakatsuka Shin-Ichi, Kumagai Toru, Okami Jiro, Higashiyama Masahiko, Imamura Fumio, Omata Mas |
| A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab. Frontiers in immunology 2021 7 12 606027. Lin Jiamao, Wang Xiaohui, Zhang Chenyue, Bu Shuai, Zhao Chenglong, Wang Haiyo |
| Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non-small-cell lung cancer. Bioengineered 2021 2 12 (1): 791-802. Zheng Songbai, Wang Xiaodan, Fu Ying, Li Beibei, Xu Jianhua, Wang Haifang, Huang Zhen, Xu Hui, Qiu Yurong, Shi Yaozhou, Li K |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
| Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist 2023 8 . Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Horton, Joseph Mock, Michael Hanley, Kyeongmin Kim, Michelle A Rudek, Mitch A Phelps, Michael A Carducci, Richard Piekarz, Kwon-Sik Park, Timothy N Bullock, Charles M Rud |
| Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer. Medicine 2023 6 102 (26): e34143. Yin JiaXin, Cong XiaoFeng, Cui PengFei, Zhao Songchen, Liu Zili |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
| NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular oncology 2023 10 . Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen-Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nish |
- Page last reviewed:Feb 1, 2024
- Content source: